BioMarin

YTD

ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO

Alexander Hardy

CEOAlexander Hardy

Employees

3,040

Employees3,040

Headquarters

San Rafael, California

HeadquartersSan Rafael, California

Founded

1997

Founded1997

Employees

3,040

Employees3,040

BMRN Key Statistics

Market cap

12.07B

Market cap12.07B

Price-Earnings ratio

28.68

Price-Earnings ratio28.68

Dividend yield

—

Dividend yield—

Average volume

1.73M

Average volume1.73M

High today

$63.87

High today$63.87

Low today

$62.19

Low today$62.19

Open price

$63.22

Open price$63.22

Volume

1.58M

Volume1.58M

52 Week high

$94.85

52 Week high$94.85

52 Week low

$52.93

52 Week low$52.93

BMRN News

Simply Wall St 2d

Is BioMarin Pharmaceutical A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the vol...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

19.4%

Sell